Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kam Yan Yu"'
Autor:
Kam Wa Chan, Kam Yan Yu, Wai Han Yiu, Rui Xue, Sarah Wing-yan Lok, Hongyu Li, Yixin Zou, Jinyuan Ma, Kar Neng Lai, Sydney Chi-wai Tang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Previous retrospective cohorts showed that Rehmannia-6 (R-6, Liu-wei-di-huang-wan) formulations were associated with significant kidney function preservation and mortality reduction among chronic kidney disease patients with diabetes. Thi
Externí odkaz:
https://doaj.org/article/fb2d86443ef848dfa3015cc6fda0e6b3
Autor:
Kam Wa Chan, Tak Yee Chow, Kam Yan Yu, Yulong Xu, Nevin Lianwen Zhang, Vivian Taam Wong, Saimei Li, Sydney Chi Wai Tang
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Previous UK Biobank studies showed that symptoms and physical measurements had excellent prediction on long-term clinical outcomes in general population. Symptoms and signs could intuitively and non-invasively predict and monitor disease
Externí odkaz:
https://doaj.org/article/dba8a2fda5ef41b69ebac8879c64b8ba
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: The quantitative effect of underlying non-communicable diseases on acute kidney injury (AKI) incidence and the factors affecting the odds of death among coronavirus disease 2019 (COVID-19) AKI patients were unclear at population level.
Externí odkaz:
https://doaj.org/article/56b325ded9de4db9b53b32e0e7862d12
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Chronic kidney disease (CKD) and diabetes are key contributors of disability-adjusted life years globally awaiting more therapeutic options. This registry-based retrospective cohort study aimed to evaluate the effectiveness, safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8941cb1e30fdbcf38ce08e8888fd60d
https://doi.org/10.1093/ndt/gfac076.020
https://doi.org/10.1093/ndt/gfac076.020
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 8 (2021)
Frontiers in Medicine, Vol 8 (2021)
Introduction: The quantitative effect of underlying non-communicable diseases on acute kidney injury (AKI) incidence and the factors affecting the odds of death among coronavirus disease 2019 (COVID-19) AKI patients were unclear at population level.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::610dde3ef1e5ab4722aae2803e7049e9
http://europepmc.org/articles/PMC8185046
http://europepmc.org/articles/PMC8185046
Autor:
Eugene Yuk-Keung Tso, Ivan Hung, Sunny Sze Ho Wong, Johnny W.M. Chan, Kam Wa Chan, Chung Man Lam, Kwok Cheung Lung, Sydney C.W. Tang, Kam Yan Yu, Gary Chi Wang Chan, Tak Chiu Wu, Owen Tak-Yin Tsang
Publikováno v:
Nephrology Dialysis Transplantation
Background and Aims Renal involvement in COVID-19 under vigilant public health surveillance, including mass screening and early hospitalization is less well-characterized. We assessed renal involvement of COVID-19 patients in Hong Kong, including the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53efb3d51c6df61e6c634db10d5a071
https://doi.org/10.1093/ndt/gfab082.0040
https://doi.org/10.1093/ndt/gfab082.0040
